Research has been conducted on the relationship between AKR1B10 and the development of digestive tumors. A review of this topic has been published, offering a new perspective on gene-targeted therapy. The study explores the pathway network of aldo-keto reductase 1b10, potentially shedding light on its role in digestive tumor development.